ATC code None CAS Number 1369764-02-2 ChemSpider 34500836 Molar mass 410.417 g/mol | Legal status Experimental drug PubChem CID 56944144 Formula C22H20F2N4O2 | |
 | ||
Lemborexant (INN) (code name E-2006) is a dual antagonist of the orexin OX1 and OX2 receptors which is under development by Eisai for the treatment of insomnia. As of December 2014, it is in phase II clinical trials.
References
Lemborexant Wikipedia(Text) CC BY-SA